Alpaca nanobodies potently neutralize SARS-CoV-2 variants

Researchers have developed a novel strategy for identifying potent miniature antibodies, so-called nanobodies, against emerging SARS-CoV-2 variants. The approach led to the discovery of multiple nanobodies that in cell cultures and mice effectively blocked infection with different SARS-CoV-2 variants. The findings could pave the way for new treatments against COVID-19.